Literature DB >> 6935580

Tetracycline discoloration, enamel defects, and dental caries in patients with cystic fibrosis.

R E Primosch.   

Abstract

The prevalence, distribution, and interrelationship between tetracycline discoloration, enamel defects, and dental caries was determined in 86 patients with cystic fibrosis (age 3 to 24 years). The dental caries experience was compared to control subjects matched for sex, race, exposure to optimally fluoridated water, chronologic age, and dental age. The findings indicate a high prevalence of tetracycline discolorations and enamel defects but a significantly reduced dental caries experience in these patients. However, interrelationships between these three factors were not strikingly evident. The presence of an altered oral health status in cystic fibrosis patients and the increased prevalence of this disease due to recent therapeutic and diagnostic advances in its management suggest the need for further familiarization with the dental manifestations of cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6935580     DOI: 10.1016/0030-4220(80)90411-9

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  16 in total

Review 1.  Dental caries prevalence in children and adolescents with cystic fibrosis: a qualitative systematic review and recommendations for future research.

Authors:  Donald L Chi
Journal:  Int J Paediatr Dent       Date:  2013-06-12       Impact factor: 3.455

2.  Requirements for ion and solute transport, and pH regulation during enamel maturation.

Authors:  Rodrigo S Lacruz; Charles E Smith; Pierre Moffatt; Eugene H Chang; Timothy G Bromage; Pablo Bringas; Antonio Nanci; Sanjeev K Baniwal; Joseph Zabner; Michael J Welsh; Ira Kurtz; Michael L Paine
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

3.  Practical management of nutrition and gastrointestinal tract in cystic fibrosis.

Authors:  M C Goodchild
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

4.  Unstimulated Saliva-Related Caries Risk Factors in Individuals with Cystic Fibrosis: A Cross-Sectional Analysis of Unstimulated Salivary Flow, pH, and Buffering Capacity.

Authors:  Alaa A Alkhateeb; Lloyd A Mancl; Richard B Presland; Marilynn L Rothen; Donald L Chi
Journal:  Caries Res       Date:  2016-11-16       Impact factor: 4.056

5.  MicroRNA 224 Regulates Ion Transporter Expression in Ameloblasts To Coordinate Enamel Mineralization.

Authors:  Yi Fan; Yachuan Zhou; Xuedong Zhou; Feifei Sun; Bo Gao; Mian Wan; Xin Zhou; Jianxun Sun; Xin Xu; Lei Cheng; Janet Crane; Liwei Zheng
Journal:  Mol Cell Biol       Date:  2015-06-08       Impact factor: 4.272

6.  The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells.

Authors:  Antonius Bronckers; Lida Kalogeraki; Huub J N Jorna; Martina Wilke; Theodore J Bervoets; Donacian M Lyaruu; Behrouz Zandieh-Doulabi; Pamela Denbesten; Hugo de Jonge
Journal:  Bone       Date:  2009-12-30       Impact factor: 4.398

Review 7.  Regulation of pH During Amelogenesis.

Authors:  Rodrigo S Lacruz; Antonio Nanci; Ira Kurtz; J Timothy Wright; Michael L Paine
Journal:  Calcif Tissue Int       Date:  2009-12-17       Impact factor: 4.333

8.  Oral health and related factors in cystic fibrosis and other chronic respiratory disorders.

Authors:  A Narang; A Maguire; J H Nunn; A Bush
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

9.  IR absorption spectrophotometric analysis of the complex formed by tetracycline and synthetic hydroxyapatite.

Authors:  H M Myers; H J Tochon-Danguy; C A Baud
Journal:  Calcif Tissue Int       Date:  1983-09       Impact factor: 4.333

10.  Age-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6-20 years: A pilot study.

Authors:  Donald L Chi; Margaret Rosenfeld; Lloyd Mancl; Whasun O Chung; Richard B Presland; Elise Sarvas; Marilynn Rothen; Alaa Alkhateeb; Sharon McNamara; Alan Genatossio; Isabel Virella-Lowell; Carlos Milla; JoAnna Scott
Journal:  J Cyst Fibros       Date:  2018-07-10       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.